NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq L

NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin

Related Keywords

Miami , Florida , United States , Naarden , Noord Holland , Netherlands , Matthew Philippe , Compensation Committee Of Newamsterdam Board Directors , Newamsterdam Pharma Companynv Nasdaq , Newamsterdam Pharma Company , Nasdaq Stock Market Of The Company , Company Contact , Compensation Committee , Nasdaq Listing Rule , Nasdaq Stock Market , Amsterdam Pharma ,